Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Contract Research & Services
Clinical Trials
Return to: PBR Home | Contract Research & Services | Clinical Trials

Clinical Trials

Pfizer reports positive results from phase III trial of Pregabalin Pfizer announced top-line results from a double-blind Phase III study evaluating pregabalin controlled-release (CR) formulation in adult patients with postherpetic neuralgia (pain after shingles or PHN).
Contract Research & Services > Clinical Trials > News
GlaxoSmithKline reports positive results from Phase III trial of shingles candidate vaccine By PBR Staff Writer
GlaxoSmithKline (GSK) has reported positive results from a Phase III trial designed to evaluate the efficacy of HZ/su, an investigational vaccine for the prevention of shingles.
Contract Research & Services > Clinical Trials > News Clementia begins natural history trial in FOP patients By PBR Staff Writer
Clementia Pharmaceuticals has started a natural history trial in patients with fibrodysplasia ossificans progressiva (FOP), a rare, severely disabling genetic disease.
Contract Research & Services > Clinical Trials > News
See more Clinical Trials news

Latest Clinical Trials News and Insight

View all Clinical Trials news or find news targeted to your interests
Pfizer begins Phase II trial of PF-06252616 to treat duchenne muscular dystrophy
By PBR Staff Writer
Pfizer has started patient enrollment in a multicenter Phase II clinical trial of PF-06252616, an experimental, infused, anti-myostatin monoclonal antibody, to treat Duchenne muscular dystrophy (DMD).
Contract Research & Services > Clinical Trials > News
Medical Research Network Goes for Transatlantic Expansion
Medical Research Network goes for Transatlantic expansion The unique Clinical Trial Support Organisation (CTSO), Medical Research Network (MRN), which offers home trial and site nurse support, as well as bespoke recruitment and retention services, has cemented its growth in Europe and the US after hiring two more professionals on either side of the Atlantic.
Contract Research & Services > Clinical Trials > Press Releases
Boehringer enrolls first patient in Phase III RE-SPECT ESUS trial of dabigatran
By PBR Staff Writer
Boehringer Ingelheim has enrolled the first patient in Phase III RE-SPECT ESUS trial designed to evaluate the efficacy and safety of dabigatran etexilate to prevent recurrent embolic stroke of undetermined source (ESUS).
Contract Research & Services > Clinical Trials > News
PRA Successfully Rescues Phase II Hematology Study
Effective Project Plan Identifies Risks, Enables Timely Transition.
Contract Research & Services > Clinical Trials > Case Studies
Meeting Enrollment Goals
Problem-Solving Leads to Early Completion of Breast Cancer Study.
Contract Research & Services > Clinical Trials > Case Studies
Persistence Leads to High Enrollment
PRA Convinces Client to Stick with Recruitment Strategies.
Contract Research & Services > Clinical Trials > Case Studies
Boehringer releases positive results from two breast cancer trials of afatinib
By PBR Staff Writer
Germany-based Boehringer Ingelheim has reported positive results from two trials (LUX-Breast 1 and LUX-Breast 3) evaluating afatinib to treat patients with breast cancer.
Contract Research & Services > Clinical Trials > News
View all Clinical Trials news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250